Every Yarn Counts in Hepatitis C
Ground-breaking clinical trial to test the effectiveness of Germicidal Ultraviolet Light to fight airborne viruses
Link revealed between maternal STIs and reduced birthweights in Papua New Guinea
Burnet supports Papua New Guinea in rolling out new treatment for drug resistant tuberculosis
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extrac...
The HIV response beyond 2030: preparing for decades of sustained HIV epidemic co...
PRECISE pregnancy cohort: challenges and strategies in setting up a biorepositor...
Harnessing the PRECISE network as a platform to strengthen global capacity for m...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Dietze P, Winter R, Pedrana A, Leicht A, Majó I Roca X, Brugal MT
Journal The International journal on drug policy
Published 30 Mar 2012
Volume 23
ISSUE 4
Pagination 257-60
DOI 10.1016/j.drugpo.2012.02.006
